54.899456, 23.915108
Biomapas
Kaunas, Lithuania
- Verified lead
- Xavier Duburcq
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information
- Review cycle
- May 2026
- Full address
- K. Donelaičio g. 60, LT-44248 Kaunas, Lithuania
- Site coordinates
- 54.899456, 23.915108
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Biomapas CEO appointment release confirming Xavier Duburcq as CEO.
- Editorial note
- Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.
Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information
GxP-aligned pharma services platform, Clinical and pharmacovigilance operating controls
Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.
Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.
- Lead
- Xavier Duburcq (verified ↗)
- Address
- K. Donelaičio g. 60, LT-44248 Kaunas, Lithuania (source ↗)
- Compliance
- GxP-aligned pharma services platform
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Pan-European clinical-services network
- Capabilities
- Clinical Trial Management · Pharmacovigilance · Regulatory Affairs
- Founded
- 2007
- Headcount
- 201-500
- Company page (open ↗)
Xavier Duburcq
Chief Executive Officer
Official Biomapas contact page listing the Kaunas headquarters address.
Open sourcePan-European clinical-services network
Kaunas, Lithuania. Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information. Review completed on 14 Mar 2026.
EU clinical, pharmacovigilance, and regulatory-services oversight
GxP-aligned pharma services platform, Clinical and pharmacovigilance operating controls
Clinical Research Operations, Pharmacovigilance, Regulatory Affairs, and Medical Information
Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways.
Biomapas is published as a Lithuanian clinical-services connector with a fresh February 25, 2026 CEO appointment and a pan-European service model.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Biomapas located?
- Biomapas operates from K. Donelaičio g. 60, LT-44248 Kaunas, Lithuania, Kaunas, Lithuania.
- Who runs Biomapas?
- Biomapas is led by Xavier Duburcq, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Biomapas hold?
- Biomapas is documented under GxP-aligned pharma services platform.
- What does Biomapas do?
- Pan-European regulatory and pharmacovigilance services engine connecting Baltic development programmes into wider EU market pathways. Core capabilities: Clinical Trial Management, Pharmacovigilance, Regulatory Affairs, Medical Information.
Related technical briefs
Briefs that name Kaunas as a covered market or city.
